15 reports

  • Gene Therapy
  • Gene Therapy

SOUTH KOREA IS ONE OF THE FIRST MOVERS IN CELL AND GENE THERAPY.

  • Gene Therapy
  • World
  • Market Size
  • Gilead Sciences, Inc.
  • Novartis AG

EXECUTIVE SUMMARY ##.

  • Gene Therapy
  • Medical Biotechnology
  • APAC
  • World
  • Market Shares
  • GENE THERAPY MARKET
  • GENE THERAPY MARKET

The company is one of the global leaders in the field of gene therapy.

  • Gene Therapy
  • United States
  • Amgen Inc.
  • Biogen Idec Inc.
  • Gilead Sciences, Inc.

Global Gene Therapy Partnering Terms and Agreements 2014 to 2019 Chapter ## – Introduction Chapter ## – Trends in Gene therapy dealmaking ##. ##.

  • Gene Therapy
  • Medical Biotechnology
  • Therapy
  • United States
  • Demand

Global Cell and Gene Therapy Market: Focus on Products, Applications, Regions and Competitive Landscape – Analysis and Forecast, 2019-2025 ## Research Scope and Methodology ##. ## Scope of the Study ##. ## Research Methodology ##. ## Data Sources ##. ## Assumptions and Limitation

  • Biopharmaceutical
  • Gene Therapy
  • Medical Biotechnology
  • World
  • Market Size
  • Hemophilia Gene Therapy Candidates (2017/2018)
  • Global Hemophilia A FVIII Gene Therapy Market Share Forecast (2030)

Gene therapy is the introduction of normal genes into cells in place of missing or defective ones in order to correct genetic disorders.

  • Gene Therapy
  • United States
  • World
  • Bayer AG
  • CSL Limited

Some approved gene therapies, like Kymriah for acute lymphoblastic leukemia (ALL) and large B cell lymphoma, have induced market players to research and develop of gene therapy for cancer treatment.

  • Gene Therapy
  • Medical Biotechnology
  • World

EXECUTIVE SUMMARY ##.

  • Gene Therapy
  • Medical Biotechnology
  • World
  • Demand
  • Objectives of Gene Therapy
  • Objectives of Gene Therapy

Parkinson' s gene therapy was one of the earlier indications I think gene therapy was actually explored in.

  • Biopharmaceutical
  • Gene Therapy
  • Therapy
  • United States
  • Product Initiative

Global Market for Gene Therapy 2019 - Product Pipeline, Market Size, & Forecasts ##.

  • Gene Therapy
  • Medical Biotechnology
  • GENE THERAPY
  • 3.5 GENE THERAPY

This is especially true when it comes to protein ## (PD- ##)/ programmed death-ligand ## (PD-L##) drugs.

  • Gene Therapy
  • United States
  • Deals & Alliance
  • M&A
  • Merck & Co., Inc.
  • 6. COMPANY PROFILES AND COMPETITIVE LANDSCAPE
  • INDIA

The increasing burden of rare diseases is one of the prime fuelling factor for the future of viral vector based gene therapy.

  • Gene Therapy
  • United States
  • World
  • Forecast
  • Market Size
  • Clinical Trial profile. 205 Trial Title

On the call, Sarepta will provide an update on encouraging ##-month functional and creatine kinase (CK) data from baseline for the ## patients in the Phase ## open-label study of Sarepta' s micro-dystrophin gene therapy candidate for Duchenne muscular dystrophy (DMD).

  • Drug Development
  • Gene Therapy
  • Pharmaceutical
  • World
  • Product Initiative
  • GENE THERAPY TO INHIBIT ALPHA SYNUCLEIN FOR PARKINSON'S DISEASE - DRUG PROFILE
  • NUMBER OF PRODUCTS BY STAGE AND MOLECULE TYPE, H2 2019

In part ##, patients will be randomized on a ##:##:## basis to receive one of two active doses (## mg or ## mg) of PRX##/ RG## or placebo via intravenous infusion once every ## weeks.

  • Gene Therapy
  • Monoclonal Antibody
  • United States
  • World
  • Product Initiative
  • Gene Therapy for Phenylketonuria
  • GENE THERAPY TO ACTIVATE PHENYLALANINE HYDROXYLASE FOR PHENYLKETONURIA - DRUG PROFILE

It has potential as a one-time gene therapy for PKU patients without dietary restrictions.

  • Endocrine Disease
  • Gene Therapy
  • Pharmaceutical
  • Therapy
  • United States